A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Clinical trial NCT07096674 · RECRUITING
Trial details
- NCT number
- NCT07096674
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2026-04-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.